Regional Director, Spain & Portugal – Diagnostics

Veracyte; España; Presencial; EUR 120.000 - 180.000; Jornada completa

Ventajas ofrecidas por este puesto de trabajo

Competitive compensation

Diversity & inclusion focus

Descripción de la vacante

Veracyte is seeking a senior commercial leader to oversee Spain & Portugal, driving market access, pricing, and reimbursement for PROSIGNA and related diagnostics. You will lead regional teams, collaborate with Marketing, Regulatory, and Medical Affairs, and develop territory strategies that maximize test adoption and health-economics value.

Preferred candidates have an MBA or advanced degree and 8+ years of leadership with P/L responsibility in oncology diagnostics or pharma, with a proven

Formación

• MBA or advanced degree strongly valued.
• 8+ years of commercial leadership experience with full revenue and P/L responsibility.
• Proven track record of launching oncology drugs or diagnostics.

Responsabilidades

• Drive adoption of PROSIGNA and new diagnostics.
• Develop go-to-market and reimbursement strategies by territory.
• Oversee regional performance, budgeting, and headcount planning.
• Lead commercial activities in compliance with quality policies and regulatory requirements.
• Manage territory operations and relationships with health authorities.

Conocimientos

Leadership

Market analysis

Oncology market knowledge

Strategic thinking

Communication skills

Cross-functional collaboration

Entrepreneurial mindset

Time management

Problem solving

Negotiation

Educación

MBA or advanced degree

Descripción del empleo

Veracyte is seeking a senior commercial leader to oversee Spain & Portugal, driving market access, pricing, and reimbursement for PROSIGNA and related diagnostics. You will lead regional teams, collaborate with Marketing, Regulatory, and Medical Affairs, and develop territory strategies that maximize test adoption and health-economics value.

Preferred candidates have an MBA or advanced degree and 8+ years of leadership with P/L responsibility in oncology diagnostics or pharma, with a proven